Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study

Subjects

Subjects :

Oncology
Cancer Research
medicine.medical_specialty
business.industry
Internal medicine
medicine
Hematology
Newly diagnosed
medicine.disease
business
Multiple myeloma

Details

ISSN :

21522650

Volume :

19

Database :

OpenAIRE

Journal :

Clinical Lymphoma Myeloma and Leukemia

Accession number :

edsair.doi...........8e3511f24bb1400e96cc5b424e45aaa8

Full Text :

https://doi.org/10.1016/j.clml.2019.09.475